Dystonia in an Adolescent on Risperidone Following the Discontinuation of Methylphenidate: A Case Report
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder with common comorbidities that include oppositional defiant disorder, conduct disorder, anxiety disorder, and affective disorders. Because of these comorbidities, drug combination treatments and drug-drug interactions are becoming increasingly more frequent. The present case report describes an acute dystonic reaction following the abrupt discontinuation of methylphenidate from a drug regimen with risperidone. The patient experienced acute dystonic reactions on three separate occasions when he forgot to take his methylphenidate medication. The present report informs clinicians about the possible side effects, such as dystonia, when psychostimulant and antipsychotic drug combinations are altered and suggests that the abrupt cessation of stimulants may lead to the development of movement disorders. Therefore, appropriate care is necessary when changing the dose of a drug or abruptly discontinuing a drug from a combination of psychostimulants and antipsychotics.
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder with common comorbidities that include oppositional defiant disorder, conduct disorder, anxiety disorder, and affective disorders. Because of these comorbidities, drug combination treatments and drug-drug interactions are becoming increasingly more frequent. The present case report describes an acute dystonic reaction following the abrupt discontinuation of methylphenidate from a drug regimen with risperidone. The patient experienced acute dystonic reactions on three separate occasions when he forgot to take his methylphenidate medication. The present report informs clinicians about the possible side effects, such as dystonia, when psychostimulant and antipsychotic drug combinations are altered and suggests that the abrupt cessation of stimulants may lead to the development of movement disorders. Therefore, appropriate care is necessary when changing the dose of a drug or abruptly discontinuing a drug from a combination of psychostimulants and antipsychotics.
참고문헌 (16)
- Tsang K., "Drug-induced movement disorders", Med Bull, 13, pp.4~5 (2008)
- McLaren JL., "Aripiprazole induced acute dystonia after discontinuation of a stimulant medication", J Clin Psychopharmacol, 30, pp.77~78 (2010)
- Rodnitzky RL., "Emergency neurology", pp.259~283 (2012), Springer Science Business Media
- Findling RL., "Evolution of the treatment of attentiondeficit", hyperactivity disorder in children : a review, 2008, pp.30, 942~957
- Silvestri S., "Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans : a clinical PET study", Psychopharmacology(Berl), 152, pp.174~180 (2000)
- Sabuncuoglu O., "Risperidone-to-methylphenidate switch reaction in children : three cases", J Psychopharmacol, 21, pp.216~219 (2007)
- Aman MG., "Risperidone effects in the presence", absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ, 2004, pp.14, 243~254
- Findling RL., "Dosing of atypical antipsychotics in children and adolescents", Primary Care Companion J Clin Psychiatry, 5(Suppl 6), pp.10~13 (2003)
- Benjamin E., "Stimulant-atypical antipsychotic interaction and acute dystonia", J Am Acad Child Adolesc Psychiatry, 44, pp.510~512 (2005)
- Keshen A., "Acute dystonic reaction in an adolescent on risperidone when a concomitant stimulant medication is discontinued", J Child Adolesc Psychopharmacol, 17, pp.867~870 (2007)
- Levine JB., "Dystonia with combined antipsychotic and stimulant treatment", J Am Acad Child Adolesc Psychiatry, 46, pp.665~666 (2007)
- Porrino LJ., "Different patterns of local brain energy metabolism associated with high and low doses of methylphenidate. Relevance to its action in hyperactive children", Biol Psychiatry, 22, pp.126~138 (1987)
- Işık E., "Güncel Temel ve Klinik Psikofarmakoloji", pp.107~122 (2008), Golden Medya
- Shen YC., "Amphetamine as a risk factor for aripiprazoleinduced acute dystonia", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.1756~1757 (2008)
- Duggal HS., "Cocaine use as a risk factor for ziprasidoneinduced acute dystonia", Gen Hosp Psychiatry, 29, pp.278~279 (2007)
- Sharp BW., "Cmap ADHD and comorbid aggression algorithm", J Am Acad Child Adolesc Psychiatry, 46, pp.1~ (2007)